Erlotinib prescribing for the second-line treatment of non-small cell lung cancer (NSCLC): The effect of National Institute for Health and Clinical Excellence (NICE) Technology Appraisal 162 (TA162)

Saved in:
Bibliographic Details
Published in:Lung cancer (Amsterdam, Netherlands) Netherlands), 2010, Vol.67, p.S6-S6
Main Authors: Banner, R, Button, M.R, Hanna, L, Brewster, A.E, Tanguay, J, Stevens, R, Lester, J.F
Format: Article
Language:English
Subjects:
Hematology, Oncology and Palliative Medicine
Pulmonary/Respiratory
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0169-5002
1872-8332
DOI:10.1016/S0169-5002(10)70017-9